Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Krytantek Ofteno PF + Gaap Ofteno PF vs Eliptic Ofteno PF + Gaap Ofteno PF in Glaucoma or Ocular Hypertension
NCT04702789Phase 4Terminated
- Sponsor
- Laboratorios Sophia
- Start
- Oct 2021
- Primary completion
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Krytantek Ofteno PF in Open-angle glaucoma (OAG), ocular hypertension, sponsored by Laboratorios Sophia. Started Oct 2021; status: terminated.
02
Drugs
Krytantek Ofteno PF
03
Conditions
Open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on NCT04702789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04702789.